AKTIS ONCOLOGY INC (AKTS) — institutional ownership
117 funds reported holding AKTIS ONCOLOGY INC in their latest 13F filings, worth $1.13B in total (CUSIP 01021M104).
Largest holders
- MPM BioImpact LLC — $156M
- EcoR1 Capital, LLC — $155M
- Blue Owl Capital Holdings LP — $99.0M
- BlackRock, Inc. (BLK) — $73.4M
- T. Rowe Price Investment Management, Inc. — $66.1M
- WELLINGTON MANAGEMENT GROUP LLP — $63.4M
- RTW INVESTMENTS, LP — $51.3M
- RA CAPITAL MANAGEMENT, L.P. — $42.4M
- Jupiter Topco LLC — $42.4M
- BAKER BROS. ADVISORS LP — $32.1M
Famous investors holding it
- George Soros portfolio (Soros Fund Management)
- Renaissance Technologies portfolio (Renaissance Technologies)
- Two Sigma portfolio (Two Sigma Investments)
- Ken Griffin portfolio (Citadel Advisors)
Insider buying and selling at AKTIS ONCOLOGY INC
Who owns the most AKTS stock?
The largest institutional holders in the latest 13F filings are MPM BioImpact LLC ($156M), EcoR1 Capital, LLC ($155M), Blue Owl Capital Holdings LP ($99.0M).
How many funds own AKTS?
117 funds reported holding it, worth $1.13B in total.